Current and Emerging Strategies for Treating Dyslipidemia and Macrovascular Disease
Author:
Publisher
Elsevier
Reference51 articles.
1. Colesevelam hydrochloride: A novel bile acid-binding resin;Aldridge;The Annals of Pharmacotherapy,2001
2. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption;Altmann;Science,2004
3. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis arterioscler;Barbier;Arteriosclerosis, Thrombosis, and Vascular Biology,2002
4. Targeting cholesterol ester transfer protein for the prevention and management of cardiovascular disease;Barter;Journal of the American College of Cardiology,2006
5. Abstract 682: Lapaqistat acetate monotherapy: Effects of a novel squalene synthase inhibitor on LDL-C levels and other lipid parameters in patients with primary hypercholesterolemia;Bays;Circulation,2007
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bile Acid Sequestrants Based on Natural and Synthetic Gels;Gels;2023-06-19
2. Transcriptomic and gene-family dynamic analyses reveal gene expression pattern and evolution in toxin-producing tissues of Asiatic toad (Bufo gargarizans);Frontiers in Ecology and Evolution;2022-07-28
3. An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia;Molecules;2020-08-26
4. Fat lowers fat: Purified phospholipids as emerging therapies for dyslipidemia;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2013-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3